Cargando…

Managing Stroke Prevention in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patients Without Confirmed Persistent Atrial Fibrillation: A Dilemma of Anticoagulation

Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic cardiovascular disorder characterized by the thickening of the heart muscle, particularly the left ventricle. It is a leading cause of sudden cardiac death in young individuals. HOCM is associated with various complications, including arrhy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henen, Christine, Johnson, Elise A, Sokol, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561532/ https://www.ncbi.nlm.nih.gov/pubmed/37818120 http://dx.doi.org/10.7759/cureus.46612

Ejemplares similares

A Case Report on the Atypical Presentation of Hypertrophic Cardiomyopathy (HOCM) in a 19-Year-Old Female
por: Alhazmi, Ahmed, et al.
Publicado: (2022)

Hypertrophic Cardiomyopathy and Atrial Fibrillation: A Review
por: Palyam, Vishnu, et al.
Publicado: (2022)

Association of Hypertrophic Obstructive Cardiomyopathy with Rheumatoid Arthritis
por: Dawood, Mustafa, et al.
Publicado: (2018)

A Cadaveric Evaluation of Hypertrophic Obstructive Cardiomyopathy
por: Murtha, Celeste M, et al.
Publicado: (2023)

A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma
por: Yasin, Ahmed K, et al.
Publicado: (2023)

Hypertension in the Setting of Hypertrophic Obstructive Cardiomyopathy and Cocaine Use
por: Miller, Daniel, et al.
Publicado: (2022)

Infective Endocarditis in Hypertrophic Obstructive Cardiomyopathy After Etonogestrel Implant Removal
por: Dlewati, Mohammad M, et al.
Publicado: (2022)

Ventricular Fibrillation Cardiac Arrest in African American Male with Apical Hypertrophic Cardiomyopathy
por: Volney, Giselle, et al.
Publicado: (2018)

Screening for Hypertrophic Obstructive Cardiomyopathy in Patients With Panic Disorder: A Case Report
por: Bonitz, Thomas, et al.
Publicado: (2022)

Physical examination in a case of hypertrophic obstructive cardiomyopathy
por: Noguchi, Masaki, et al.
Publicado: (2023)

DKA-Induced Takotsubo Cardiomyopathy in Patient with Known HOCM
por: Gordon, Ayla, et al.
Publicado: (2017)

A Case of an Acutely Ill Adult Athlete with Previously Undiagnosed Hypertrophic Obstructive Cardiomyopathy
por: Minckler, Michael R, et al.
Publicado: (2019)

Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
por: Filho, André Inocêncio Novaes Lima, et al.
Publicado: (2022)

Takotsubo Cardiomyopathy in a Patient with Preexisting Hypertrophic Cardiomyopathy
por: Elhosseiny, Sherif, et al.
Publicado: (2018)

Acute Mesenteric Ischemia in a Chronically Anticoagulated Patient With Atrial Fibrillation: Anticoagulation Reversal, Management and Preventing Recurrence
por: Aziz, Ahmed Ali, et al.
Publicado: (2022)

Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls
por: Shanah, Layla, et al.
Publicado: (2020)

Takotsubo Cardiomyopathy in the Setting of Hypertrophic Cardiomyopathy Following Pacemaker Implantation
por: Boghdadi, George, et al.
Publicado: (2023)

Comment on “DKA-Induced Takotsubo Cardiomyopathy in Patient with Known HOCM”
por: Madias, John E.
Publicado: (2017)

Co-Existing Subaortic Stenosis in a Patient With Hypertrophic Obstructive Cardiomyopathy: A Rare and Interesting Finding
por: Mushtaque, Raja S, et al.
Publicado: (2020)

Subaortic Membrane With Mitral Chordae Rupture Mimicking Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
por: Choukair, Mohamad Omar, et al.
Publicado: (2021)

Persistent Atrium Standstill Post Atrial Fibrillation Ablation Therapy
por: Khatoun, Maya A, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy
por: Narita, Koichi, et al.
Publicado: (2020)

Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
por: Akman, Canan, et al.
Publicado: (2021)

Perianesthetic management of a patient with hypertrophic obstructive cardiomyopathy (HOCM) with left ventricular outflow tract gradient of 150 mmHg undergoing Whipple’s surgery
por: Punj, Jyotsna, et al.
Publicado: (2022)

Management of a Rare Variant of Hypertrophic Cardiomyopathy
por: Khalid, Sidra, et al.
Publicado: (2018)

Bilateral Renal Infarction Secondary to Hypertrophic Cardiomyopathy
por: Farooqi, Rehan, et al.
Publicado: (2019)

Pheochromocytoma and Hypertrophic Cardiomyopathy Leading to Cardiac Arrest
por: Niu, Kevyn, et al.
Publicado: (2023)

Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
por: Sandhu, Osama, et al.
Publicado: (2020)

Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Wang, Shengnan, et al.
Publicado: (2023)

A Rare Case of Mass-Like Hypertrophic Cardiomyopathy
por: Shuroog, Juwairiya, et al.
Publicado: (2021)

Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review
por: Al Rawahi, Mohamed N, et al.
Publicado: (2023)

Cardiac Tamponade Risk Associated With Anticoagulation for Atrial Fibrillation in Dialysis-Associated Pericarditis: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Salah, Qais M, et al.
Publicado: (2023)

Amyloidosis with phenotype of hypertrophic cardiomyopathy
por: Kuryła, Martyna, et al.
Publicado: (2023)

Familial Hypertrophic Cardiomyopathy: Late Potentials and Other Prognostic Markers
por: Chaves-Markman, Ândrea, et al.
Publicado: (2020)

The Ace of Spades: Apical Hypertrophic Cardiomyopathy in an African Male Patient
por: Rugbeer, Yashvir, et al.
Publicado: (2022)

Ischemic Stroke in a Patient With Atrial Tachycardia, Methylenetetrahydrofolate Reductase Mutation and New-Onset Atrial Fibrillation: Is Early Initiation of Anticoagulation Therapy Indicated?
por: Eyituoyo, Harry O, et al.
Publicado: (2020)

Thromboembolic Events in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation During New Oral Anticoagulant Therapy
por: An, Myeonghyun, et al.
Publicado: (2023)

Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Jyotsna, FNU, et al.
Publicado: (2023)

Diagnosis and Management of a Cardiac Amyloidosis Case Mimicking Hypertrophic Cardiomyopathy
por: Sattar, Yasar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_86gn7kn5r7qmjn687bov0vb4qb